Filing Analysis
BeyondSpring Inc. filed an 8-K to announce its financial results for the quarter ended June 30, 2026. The filing serves as a formal announcement of the earnings release via Exhibit 99.1.
📋 Key Facts
- Company announced financial results for the fiscal quarter ending June 30, 2026.
- The announcement was made on August 14, 2026.
- Financial results were released via a press release (Exhibit 99.1).
This 8-K/A amendment discloses the finalized compensation arrangements for newly appointed CEO Min Qiu. The filing details his salary, bonus structure, and equity incentives following his appointment originally reported on June 4, 2026.
🚩 Red Flags
- Low base salary ($100,000) relative to typical micro-cap CEO compensation may indicate tight liquidity or early-stage company status.
📋 Key Facts
- Min Qiu appointed as Chief Executive Officer (CEO).
- Annual base salary of $100,000 for Mr. Qiu.
- Target annual bonus of 30% of base salary via company-sponsored programs.
- Grant of 100,000 ordinary shares via options, vesting in four equal annual installments.
- Severance package includes 9 months of base salary and pro-rated bonus for termination without cause or resignation for good reason.
- Change in control provisions include immediate vesting of unvested options if not assumed/substituted.
BeyondSpring Inc. announced a significant leadership overhaul effective July 1, 2026, including the transition of Dr. Lan Huang from CEO to Chair of the Board and the appointment of Mr. Min Qiu as CEO and Ms. Na Li as CFO.
🚩 Red Flags
- Simultaneous replacement of both the CEO and CFO, which can indicate internal instability or a major strategic pivot.
- Employment agreements and compensatory arrangements for the new CEO and CFO have not yet been finalized as of the filing date.
📋 Key Facts
- Dr. Lan Huang will step down as CEO on July 1, 2026, but remain as Chair of the Board.
- Mr. Min Qiu is appointed as the new CEO effective July 1, 2026; he previously served as Vice General Manager of subsidiary Wanchunbulin.
- Ms. Na Li is appointed as the new CFO effective July 1, 2026; she has been CFO of Wanchunbulin since November 2020.
- Dr. Jiangwen Majeti is appointed Vice Chair of the Board and granted 100,000 share options vesting over four years.
- Dr. Lan Huang will forfeit all unvested equity and long-term incentive awards upon her transition on July 1, 2026.
BeyondSpring Inc. announced its financial results for the first quarter ended March 31, 2026, via a press release furnished under Item 2.02.
📋 Key Facts
- The filing reports financial results for the quarter ended March 31, 2026.
- The press release was issued and furnished on May 13, 2026.
- The information is furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.
BeyondSpring Inc. announced its financial results for the full fiscal year ended December 31, 2025, via a press release on March 25, 2026. The filing serves as a standard regulatory disclosure of annual performance results.
📋 Key Facts
- The report was filed on March 25, 2026, covering the fiscal year ended December 31, 2025.
- The disclosure was made under Item 2.02 (Results of Operations and Financial Condition).
- Exhibit 99.1 contains the detailed press release regarding the financial results.
- The filing was signed by Chairperson and CEO Lan Huang.
BeyondSpring Inc. provided an update regarding the status of its Series A-1 Preferred Share purchase agreements involving SEED Therapeutics Inc. While certain share purchases were scheduled for completion by December 15, 2025, the 'Second Closings' are now expected to be delayed until the first half of 2026.
🚩 Red Flags
- Delay in expected capital infusion: The Second Closings, originally tied to a December 15, 2025 deadline, are pushed into the first half of 2026.
- Uncertainty regarding timing and completion of significant asset/share monetization.
📋 Key Facts
- The company is selling an aggregate of 8,333,637 Series A-1 Preferred Shares of SEED Therapeutics Inc. at $4.25 per share.
- Total transaction value for the shares is approximately $35.4 million.
- Three investors (Winning View Investment Limited, FULL TECH CORPORATE DEVELOPMENT LIMITED, and Mapfil Investment Limited) had scheduled purchases due by December 15, 2025.
- The 'Second Closings' are now expected to be completed in the first half of 2026.
- Management noted there is no assurance that these closings will not be further delayed.
BeyondSpring Inc. entered into a Securities Purchase Agreement with Ray Beauty Group Limited to issue 800,000 ordinary shares at $2.50 per share. The transaction resulted in gross proceeds of $2.0 million and closed on November 21, 2025.
🚩 Red Flags
- Small capital raise ($2M) may indicate a need for immediate liquidity in a micro-cap context.
📋 Key Facts
- Investor: Ray Beauty Group Limited
- Number of shares issued: 800,000 ordinary shares
- Price per share: $2.50
- Total gross proceeds: $2.0 million (before expenses)
- Closing date: November 21, 2025
- Lock-up period: 60 days from the date of closing
- Registration basis: Form S-3 (File No. 333-280153) effective August 18, 2025
BeyondSpring Inc. filed an 8-K to announce its financial results for the quarter ended September 30, 2025. The filing serves as a placeholder to furnish the earnings press release via Exhibit 99.1.
📋 Key Facts
- Report date: November 12, 2025
- Reporting period: Quarter ended September 30, 2025
- The filing includes a press release as Exhibit 99.1 regarding financial results.
BeyondSpring Inc. announced the completion of a 'second close' for SEED Therapeutics, involving the sale of 1,411,761 Series A-3 Preferred Shares to third-party investors for $6 million. This transaction results in BeyondSpring and its subsidiary owning approximately 38.03% of SEED Therapeutics on an as-converted basis.
🚩 Red Flags
- Dilution: The issuance of new shares to third-party investors dilutes existing shareholders' percentage ownership in SEED Therapeutics.
📋 Key Facts
- SEED Therapeutics completed a second close of share purchases on September 22, 2025.
- The sale involved 1,411,761 Series A-3 Preferred Shares at $4.25 per share.
- Total proceeds from this specific tranche amounted to $6 million.
- BeyondSpring and its subsidiary SEED Technology Limited now hold ~38.03% of SEED's outstanding equity on an as-converted basis.
- The company expects to continue consolidating SEED into its financial statements due to substantive control.
BeyondSpring Inc. held its 2025 annual meeting of shareholders on September 15, 2025. The primary outcome was the ratification of CBIZ CPAs P.C. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025.
📋 Key Facts
- Annual meeting held on September 15, 2025.
- Total shares present/represented: 21,852,265 (approx. 54.19% of outstanding shares).
- CBIZ CPAs P.C. was ratified as the independent registered public accounting firm for FY2025.
- Ratification vote details: 21,831,390 For; 14,265 Against; 6,610 Abstain.
BeyondSpring Inc. filed an 8-K to announce the release of its financial results for the quarter ended June 30, 2025.
📋 Key Facts
- The company issued a press release on August 13, 2025, regarding quarterly financial results.
- The reporting period covered is the quarter ending June 30, 2025.
- The filing includes Exhibit 99.1 containing the full press release.
BeyondSpring Inc. has announced the scheduling of its 2025 Annual Meeting of Shareholders, set for September 15, 2025.
📋 Key Facts
- The 2025 Annual Meeting is scheduled for September 15, 2025.
- The record date for shareholders to be eligible to vote is the close of business on July 25, 2025.
- Shareholder proposals must be received by July 14, 2025, to be included in the Proxy Statement.
BeyondSpring Inc. filed an 8-K to announce its quarterly financial results for the period ended March 31, 2025. The filing serves as a formal mechanism to furnish the earnings press release (Exhibit 99.1) to the SEC.
📋 Key Facts
- Report date: May 12, 2025
- Reporting period: Quarter ended March 31, 2025
- The filing includes a press release as Exhibit 99.1 regarding financial results
- Company is listed on the NASDAQ Stock Market under ticker BYSI
BeyondSpring Inc. announced the resignation of its independent auditor, Marcum LLP, effective April 8, 2025. The company has appointed CBIZ as its new independent registered public accounting firm.
🚩 Red Flags
- Auditor change (Marcum LLP resigned).
- Previous audit report for FY2023 included a 'going concern' warning/explanatory paragraph.
- Potential risk of delayed financial filings due to the transition between auditors.
📋 Key Facts
- Marcum LLP resigned as the Company's independent registered public accounting firm on April 8, 2025.
- CBIZ CPAs P.C. was engaged as the new independent auditor on April 9, 2025.
- The company stated there were no disagreements with Marcum regarding accounting principles or auditing procedures.
- The audit report for the fiscal year ended December 31, 2023, contained an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.
BeyondSpring Inc. issued an 8-K to announce its full-year financial results for the fiscal year ended December 31, 2024.
📋 Key Facts
- Report date: March 27, 2025
- Reporting period: Full year ended December 31, 2024
- The filing includes a press release (Exhibit 99.1) regarding financial results.
- The information is furnished rather than filed under Section 18 of the Exchange Act.
BeyondSpring Inc. has completed the first closing of a significant asset sale involving SEED Therapeutics Inc. shares, receiving $7.35 million in cash. The company is executing a multi-stage divestiture of its core assets to multiple buyers for an expected total of approximately $35.4 million.
🚩 Red Flags
- Significant asset disposition: The company is selling off a 'significant amount' of its assets (SEED Therapeutics shares), which likely represents its primary value driver.
- Uncertainty of future closings: Management notes there is no assurance that all remaining transfers will occur or that actual results will match pro forma projections.
- Liquidation profile: The structured, multi-year sale of core assets often indicates a company transitioning toward liquidation or a shell entity.
📋 Key Facts
- Completed 'First Closing' on February 19, 2025.
- Transferred 1,730,454 Series A-1 Preferred Shares of SEED Therapeutics Inc. to three buyers: Winning View Investment Limited (980,427), FULL TECH CORPORATE DEVELOPMENT LIMITED (250,009), and Mapfil Investment Limited (500,018).
- Received $7,354,432.75 in cash proceeds from the first closing.
- Total contemplated sale involves 8,333,637 shares for an aggregate price of ~$35.4 million.
- The company expects to complete remaining transfers by the end of 2026.
- An amendment was signed on February 17, 2025, increasing the first closing transfer to Winning View Investment Limited by 230,400 shares for an additional $979,203.25.
BeyondSpring Inc. entered into agreements to sell 8,333,637 Series A-1 Preferred Shares of its subsidiary, SEED Therapeutics Inc., for approximately $35.4 million at $4.25 per share. The sale will be executed in multiple installments through December 2026 by three different buyers.
🚩 Red Flags
- The transaction involves a subsidiary (SEED Therapeutics Inc.) rather than the parent company directly, which may impact immediate cash flow to BeyondSpring Inc. depending on the structure of the proceeds.
- Multi-year installment plan suggests the capital infusion is spread out over 24 months rather than being an immediate lump sum.
📋 Key Facts
- Aggregate sale price: ~$35.4 million
- Share price: $4.25 per Series A-1 Preferred Share
- Total shares to be sold: 8,333,637
- Buyers: Winning View Investment Limited, FULL TECH CORPORATE DEVELOPMENT LIMITED, and Mapfil Investment Limited
- Installment structure: Payments/share issuances are scheduled in three tranches ending December 15, 2026
- Post-transaction ownership of SEED by BYSI entities is expected to be significantly reduced (remaining interests approx. 41.02%, 28.02%, and 14.37% for the respective buyers' interest/BYSI structure context)
BeyondSpring Inc. is announcing its transition from a 'foreign private issuer' to a domestic filer, effective January 1, 2025. This change requires the company to file more detailed and prompt periodic reports with the SEC.
🚩 Red Flags
- None identified in this specific filing.
📋 Key Facts
- Effective date of status change: January 1, 2025.
- Company is transitioning from 'foreign private issuer' to a domestic filer for SEC reporting purposes.
- The company will now be required to file more detailed and extensive periodic reports and registration statements than previously required.